ask="2.950"
ask_size="200"
average_daily_volume="712040"
bid="N/A"
bid_size="N/A"
book_value="1.067"
change="+0.084"
change_from_200_day_moving_average="-0.346"
change_from_50_day_moving_average="0.041"
change_from_52_week_high="-4.184"
change_From_52_week_low="0.624"
change_in_percent="+5.600%"
close="1.584"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.006"
ebitda="-16.58M"
eps_estimate_current_year="-2.910"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-1.370"
ex_dividend_date="N/A"
float_shares="5083000"
high="1.640"
high_52_weeks="5.768"
last_trade_date="2/27/2017"
last_trade_price="1.584"
last_trade_size="500"
last_trade_time="3:56pm"
low="1.470"
low_52_weeks="0.960"
market_capitalization="18.52M"
moving_average_200_day="1.930"
moving_average_50_day="1.543"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.000"
open="1.470"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-17.943%"
percent_change_from_50_day_moving_average="+2.626%"
percent_change_from_52_week_high="-72.538%"
percent_change_from_52_week_low="+65.000%"
previous_close="1.500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.406"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.210"
stock_exchange="NCM"
symbol="PZRX"
volume="16036"
weeks_range_52="0.960 - 5.768"
